drugset / Trial / NCT03234660

Dexmedetomidine and Neuroprotection in Children Undergoing General Anesthesia

NCT03234660 ↗

Completed 60 enrolled Seoul National University Hospital
RandomizedParallel-groupQuadruple-blindDiagnostic

Summary

Neuroapoptosis is induced by the administration of anesthetic agents to the young brain. Recent studies showed that the a2-adrenoceptor agonist, dexmedetomidine plays a trophic role during development and is neuroprotective in several settings of neuronal injury in animals. We hypothesized that neuroprotective effect of dexmedetomidine would be associated with evidence of brain injury detected by elevation of plasma concentration of glial fibrillary acid protein in children undergoing general anesthesia.

Timeline

Start
2017-09-01
Primary completion
2019-10-05
Completion
2019-10-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg —

Indications

No indication recorded.